Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently without UK marketing authorisation from the MHRA or EMA
These would include, for example, antacid medications that inhibit the bodys production of stomach acid, anti-cholesterol medications that block the production of cholesterol, and selective serotonin reuptake inhibitors (SSRIs) that block the uptake of serotonin to treat depression
Targets the cellular drivers of aging to preserve youthful texture and glow
If you're looking for a modern approach that gives you extra advantages by regulating the hormones involved in weight management, GLP-1 could be right for you
July 27, 2011
However, Im now usually first prescribing sporulating probiotics